Total planned funding: $122,304,220
Allocations
Countries/Regions
Ukraine | $122,304,220 |
Organizational Types
Unknown | $32,668,021 |
Private Contractor | $29,078,578 |
NGO | $21,862,998 |
Own Agency | $12,905,343 |
Multi-lateral Agency | $11,438,586 |
University | $5,017,000 |
Other USG Agency | $4,711,694 |
Implementing Agency | $4,372,000 |
Host Country Government Agency | $250,000 |
Program Areas
Governance and Systems | $52,276,285 |
Treatment | $22,528,502 |
Prevention | $17,296,263 |
Testing | $10,410,677 |
Care | $10,054,872 |
Management and Operations | $9,324,921 |
Budget Codes
OHSS: Health Systems Strengthening | $27,672,609 |
HVSI: Strategic Information | $13,118,201 |
HLAB: Laboratory Infrastructure | $11,485,475 |
HTXD: Treatment: ARV Drugs | $11,431,114 |
HTXS: Treatment: Adult Treatment | $11,097,388 |
HVCT: Testing: HIV Testing and Counseling | $10,410,677 |
HVMS: Management and Operations | $9,324,921 |
IDUP: Prevention: Injecting and Non-Injecting Drug Use | $7,353,306 |
HVOP: Sexual Prevention: Other Sexual Prevention | $6,928,982 |
HVTB: Care: TB/HIV | $6,240,814 |
HMBL: Biomedical Prevention: Blood Safety | $2,251,624 |
HKID: Care: Orphans and Vulnerable Children | $2,124,506 |
HBHC: Care: Adult Care and Support | $1,689,552 |
MTCT: Biomedical Prevention: Prevention of Mother to Child Transmission | $293,357 |
HMIN: Biomedical Prevention: Injection Safety | $250,000 |
HVAB: Sexual Prevention: Abstinence/Be Faithful | $218,994 |
Top Partner Programs
Not Available:
$33,372,737
Countries/Regions
Chemonics International:
$16,839,470
Countries/Regions
USG Aggregated Agencies:
$11,556,343
Countries/Regions
Deloitte Consulting Limited:
$10,239,108
Countries/Regions